<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Vasodilators: antihypertensive; Antihypertensives: vasodilator; Diazoxide: hypertension; Hydralazine; Sodium nitroprusside; Nitroprusside see Sodium nitroprusside; Minoxidil: hypertension; Pulmonary: hypertension; Hypertension: pulmonary; Ambrisentan; Bosentan; Iloprost; Sildenafil: pulmonary hypertension; Tadalafil: pulmonary hypertension; Epoprostenol; Systemic sclerosis; Digital ulcer disease; Sitaxentan" /><meta name="IX" content="Vasodilators: antihypertensive; Antihypertensives: vasodilator; Diazoxide: hypertension; Hydralazine; Sodium nitroprusside; Minoxidil: hypertension; Pulmonary: hypertension; Hypertension: pulmonary; Ambrisentan; Bosentan; Iloprost; Sildenafil: pulmonary hypertension; Tadalafil: pulmonary hypertension; Epoprostenol; Systemic sclerosis; Digital ulcer disease; Sitaxentan" /><meta name="IXN" content="Nitroprusside see Sodium nitroprusside" /><title>2.5.1 Vasodilator antihypertensive drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1040-vasodilator-antihypertensive-drugs.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1040-vasodilator-antihypertensive-drugs.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1040-vasodilator-antihypertensive-drugs.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1034-hypertension-and-heart-failure.htm">2.5 Hypertension and heart failure</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1034-hypertension-and-heart-failure.htm" title="Previous: 2.5 Hypertension and heart failure">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1042-ambrisentan.htm" title="Next: AMBRISENTAN">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>2.5.1 </span>Vasodilator antihypertensive drugs</h1><?highlighter on?><div id="pC" class="jN"><p>Vasodilators have a potent hypotensive effect, especially when used in combination with a beta-blocker and a thiazide. <strong>Important:</strong> for a warning on the hazards of a very rapid fall in blood pressure, see <a title="target-block: Accelerated or very severe hypertension" href="PHP1034-hypertension-and-heart-failure.htm#PHP1039">Hypertensive crises</a>.</p> <p><strong>Diazoxide</strong> has been used by intravenous injection in hypertensive emergencies, however alternative treatments are preferred (<a title="BNF:target-block: Accelerated or very severe hypertension" href="PHP1034-hypertension-and-heart-failure.htm#PHP1039">see section 2.5</a>)</p> <p><strong>Hydralazine</strong> is given by mouth as an adjunct to other antihypertensives for the treatment of resistant hypertension but is rarely used; when used alone it causes tachycardia and fluid retention. The incidence of side-effects is lower if the dose is kept below 100 mg daily, but systemic lupus erythematosus should be suspected if there is unexplained weight loss, arthritis, or any other unexplained ill health. </p> <p><strong>Sodium nitroprusside</strong> [unlicensed] is given by intravenous infusion to control severe hypertensive emergencies when parenteral treatment is necessary. </p> <p id="PHP1041"><strong>Minoxidil</strong> should be reserved for the treatment of severe hypertension resistant to other drugs. Vasodilatation is accompanied by increased cardiac output and tachycardia and the patients develop fluid retention. For this reason the addition of a beta-blocker and a diuretic (usually furosemide, in high dosage) are mandatory. Hypertrichosis is troublesome and renders this drug unsuitable for women. </p> <p>Prazosin, doxazosin, and terazosin (<a title=" Alpha-adrenoceptor blocking drugs" href="PHP1088-alpha-adrenoceptor-blocking-drugs.htm">section 2.5.4</a>) have alpha-blocking and vasodilator properties.</p> <p><strong>Ambrisentan</strong>, <strong>bosentan</strong>, <strong>iloprost</strong>, <strong>sildenafil</strong>, and <strong>tadalafil</strong> are licensed for the treatment of pulmonary arterial hypertension and should be used under specialist supervision. <strong>Epoprostenol</strong> (<a title="monograph-family: Epoprostenol" href="PHP1478-epoprostenol.htm">section 2.8.1</a>) can be used in patients with primary pulmonary hypertension resistant to other treatments. Bosentan is also licensed to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease.</p> <p><strong>Sitaxentan</strong> has been withdrawn from the market because the benefit of treatment does not outweigh the risk of severe hepatotoxicity.</p> <p>The <a title="target-block: NICE and Scottish Medicines Consortium" href="PHP60-general-guidance.htm#PHP70"><em>Scottish Medicines Consortium</em></a> has advised (November 2005) that iloprost (<em>Ventavis</em>®) is accepted for restricted use within NHS Scotland in patients in whom bosentan is ineffective or not tolerated, and should only be prescribed by specialists in the Scottish Pulmonary Vascular Unit.</p> <p>The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="PHP60-general-guidance.htm#PHP70"><em>Scottish Medicines Consortium</em></a> has advised (October 2008) that ambrisentan (<em>Volibris</em>®) should be prescribed only by specialists in the Scottish Pulmonary Vascular Unit or other similar specialists.</p> <p>The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="PHP60-general-guidance.htm#PHP70"><em>Scottish Medicines Consortium</em></a> has advised (January 2010 and February 2011) that sildenafil tablets (<em>Revatio</em>®) should be initiated only by specialists in the Scottish Pulmonary Vascular Unit or other similar specialists and that sildenafil injection (<em>Revatio</em>®) should be prescribed only on the advice of specialists in the Scottish Pulmonary Vascular Unit or the Scottish Adult Congenital Cardiac Service.</p> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP1042-ambrisentan"><a href="PHP1042-ambrisentan.htm" title="AMBRISENTAN">AMBRISENTAN</a></li><li id="_PHP1044-bosentan"><a href="PHP1044-bosentan.htm" title="BOSENTAN">BOSENTAN</a></li><li id="_PHP1046-diazoxide"><a href="PHP1046-diazoxide.htm" title="DIAZOXIDE">DIAZOXIDE</a></li><li id="_PHP1048-hydralazine-hydrochloride"><a href="PHP1048-hydralazine-hydrochloride.htm" title="HYDRALAZINE HYDROCHLORIDE">HYDRALAZINE HYDROCHLORIDE</a></li><li id="_PHP1052-iloprost"><a href="PHP1052-iloprost.htm" title="ILOPROST">ILOPROST</a></li><li id="_PHP1055-minoxidil"><a href="PHP1055-minoxidil.htm" title="MINOXIDIL">MINOXIDIL</a></li><li id="_PHP1059-sildenafil"><a href="PHP1059-sildenafil.htm" title="SILDENAFIL">SILDENAFIL</a></li><li id="_PHP1065-sodium-nitroprusside"><a href="PHP1065-sodium-nitroprusside.htm" title="SODIUM NITROPRUSSIDE">SODIUM NITROPRUSSIDE</a></li><li id="_PHP1067-tadalafil"><a href="PHP1067-tadalafil.htm" title="TADALAFIL">TADALAFIL</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1034-hypertension-and-heart-failure.htm">Previous: 2.5 Hypertension and heart failure</a> | <a class="top" href="PHP1040-vasodilator-antihypertensive-drugs.htm#">Top</a> | <a accesskey="]" href="PHP1042-ambrisentan.htm">Next: AMBRISENTAN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>